Search





Search





Markets
/
Stocks
/
xene
/

Xenon Pharmaceuticals Inc

XENE

Add to Watchlist

62.670USD

-1.520-2.37%

Close 07-31 16:00（ET）Quotes delayed by 15 min

6.06BMarket Cap

LossP/E TTM

Xenon Pharmaceuticals Inc

62.670

-1.520-2.37%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

10.00

Change

The current institutional shareholding score of Xenon Pharmaceuticals Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 116.66%, representing a quarter-over-quarter increase of 21.96%. The largest institutional shareholder is Paul Tudor Jones, holding a total of 534.69K shares, representing 0.51% of shares outstanding, with 0.53% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

6.20M

-0.80%

Avoro Capital Advisors LLC

5.42M

+0.45%

Wellington Management Company, LLP

4.76M

+31.99%

Driehaus Capital Management, LLC

4.54M

+8.86%

BlackRock Institutional Trust Company, N.A.

4.28M

+5.52%

Janus Henderson Investors

4.08M

+3.55%

Capital International Investors

3.41M

+7.34%

Polar Capital LLP

2.47M

-3.18%

Fidelity Institutional Asset Management

2.14M

+2.52%

Braidwell LP

1.83M

-49.37%